Catalyst Wire Dossier Catalyst Wire Dossier

LIDOCAN

Lidocaine 5% · PURETEK CORPORATION
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LIDOCAN, covering 2020-04-30 to 2020-04-30. Get the full timeline:

Most recent: FDA Approved: LIDOCAN — Original Application (PURETEK CORPORATION)

See pricing